This article reviews pharmacological, animal, and human evidence regarding the abuse liability of methylphenidate (MPH). Findings are not always consistent, but evidence converges to suggest that although intravenous methylphenidate has some abuse potential, there is very little potential for oral MPH abuse. Furthermore, the available data suggests that children with Attention-Deficit/Hyperactivity Disorder (ADHD) who are treated with MPH are at lower risk for substance use disorder later in life. More longitudinal, prospective studies are needed to assess the long term effects of MPH treatment in ADHD.
Get full access to this article
View all access options for this article.
References
1.
AndersenS. L., ArvanitogiannisA., PliakasA. M., LeBlancC., & CarlezonW. A.Jr. (2002). Altered responsiveness to cocaine in rats exposed to methylphenidate during development.Natural Neuroscience, 5(1), 13–14.
2.
BiedermanJ., WilensT., MickE., SpencerT., & FaraoneS. V.. (1999). Pharmacotherapy of Attention-Deficit/Hyperactivity Disorder reduces risk for substance use disorder.Pediatrics, 104(2), 20.
3.
BrandonC. L., MarinelliM., BakerL. K., & WhiteF. J.. (2001). Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats.Neuropsychopharmacology, 25(5), 651–661.
4.
BregginP. R., & BaughmanF. A.. (2001). Questioning the treatment for ADHD.Science, 291, 595.
5.
CarlezonW. A.Jr., ThomeJ., OlsonV. G., Lane-LaddS. B., BrodkinE. S., HiroiN. (1998). Regulation of cocaine reward by CREB.Science, 282(5391), 2272–2275.
6.
D'AgostinoR. B.. (1998). Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.Statistical Medicine, 17, 2265–2281.
7.
EverittB. J., DickinsonA., & RobbinsT. W.. (2001). The neuropsychological basis of addictive behavior.Brain Research Reviews, 36(2-3), 129–138.
FergussonD., LynskeyM., & HorwoodL.. (1997). Attentional difficulties in middle childhood and psychosocial outcomes in young adulthood.Journal of Child Psychology and Psychiatry, 38(6), 633–644.
10.
GillbergC., MelanderH., von KnorringA. L., JanolsL. O., ThernlundG., HagglofB. (1997). Long-term stimulant treatment of children with Attention-Deficit Hyperactivity Disorder symptoms. A randomized, double-blind, placebo-controlled trial.Archives of General Psychiatry, 54(9), 857–864.
11.
GoodwinA. K., & BakerL. E.. (2002). An analysis of the utility of differential outcome procedures in drug discrimination research.Behavioural Pharmacology, 13(4), 271–278.
12.
HechtmanL.. (1985). Adolescent outcome of hyperactive children treated with stimulants in childhood: A review.Psychopharmacological Bulletin, 21(2), 178–191.
13.
HeyneA., & WolffgrammJ.. (1998). The development of addiction to d-amphetamine in an animal model: Same principles as for alcohol and opiate.Psychopharmacology (Berl), 140(4), 510–518.
14.
HoebelB. G., MonacoA. P., HernandezL., AulisiE. F., StanleyB. G., & LenardL.. (1983). Self-injection of amphetamine directly into the brain.Psychopharmacology, 81(2), 158–163.
15.
HussM., EnglertE., LehmkuhlG., PoustkaF., & LehmkuhlU.. (2002). Early methylphenidate treatment in ADHD children reduces risk for adult substance abuse. Manuscript in preparation.
16.
JohansonC. E., & BarrettJ. E.. (1993). The discriminative stimulus effects of cocaine in pigeons.Journal of Pharmacology and Experimental Therapeutics, 267(1), 1–8.
17.
KamienJ. B., BickelW. K., HughesJ. R., HigginsS. T., & SmithB. J.. (1993). Drug discrimination by humans compared to nonhumans: Current status and future directions.Psychopharmacology (Berl), 111(3), 259–270.
18.
KelzM. B., ChenJ., CarlezonW. A., WhislerK., GildenL., BeckmannA. M. (1999). Expression of the transcription factor deltaFosB in the brain controls sensitivity to cocaine.Nature, 401(6750), 272–276.
19.
KleinR. G., & MannuzzaS.. (2002). Stimulant sensitization in children.Journal of Attention Disorders, 6(Supplement 1), 61–64.
20.
KollinsS. H., MacDonaldE. K., & RushC. R.. (2001). Assessing the abuse potential of methylphenidate in nonhuman and human subjects: A review.Pharmacology, Biochemistry, and Behavior, 68(3), 611–627.
KotlyarM., GoldingM., HatsukamiD. K., & JamersonB. D.. (2001). Effect of nonnicotine pharmacotherapy on smoking behavior.Pharmacotherapy, 21(12), 1530–1548.
23.
LambertN., & HartsoughC.. (1998). Prospective study of tobacco and substance dependencies among samples of ADHD and non-ADHD participants.Journal of Learning Disabilities, 31, 533–544.
24.
LynskeyM. T., & HallW.. (2001). Attention Deficit Hyperactivity Disorder and substance use disorders: Is there a causal link?Addiction, 96, 815–822.
25.
OldsJ.. (1969). The central nervous system and the reinforcement of behavior.The American Psychologist, 24(2), 114–132.
26.
ParranT. V., & JasinskiD. R.. (1991). Intravenous methylphenidate abuse: Prototype for prescription drug abuse.Archives of Internal Medicine, 151, 781–783.
27.
RobbinsT. W.. (2002). ADHD and addiction.Nature Medicine, 8(1), 24–25.
28.
RobbinsT. W., & EverittB. J.. (1999). Drug addiction: Bad habits add up.Nature, 398, 567–570.
29.
RoehrsT., PapineauK., RosenthalL., & RothT.. (1999). Sleepiness and the reinforcing and subjective effects of methylphenidate.Experimental and Clinical Psychopharmacology, 7(2), 145–150.
30.
VolkowN. D., DingY. S., FowlerJ. S., WangG. J., LoganJ., GatleyJ. S. (1995). Is methylphenidate like cocaine? Studies on their pharmacokinetics and distribution in the human brain.Archives of General Psychiatry, 52(6), 456–63.
31.
VolkowN. D., WangG. J., FowlerJ. S., GatleyS. J., LoganJ., DingY. S. (1999). Blockade of striatal dopamine transporters by intravenous methylphenidate is not sufficient to induce self-reports of “high.”The Journal of Pharmacology and Experimental Therapeutics, 288(1), 14–20.
32.
VolkowN. D., WangG., FowlerJ. S., LoganJ., GerasimovM., MaynardL. (2001). Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain.Journal of Neuroscience, 21(2), RC121, 1-5.
33.
VolkowN. D., WangG. J., FowlerJ. S., LoganJ., SchlyerD., HitzemannR. (1994). Imaging endogenous dopamine competition with [11C]raclopride in the human brain.Synapse, 16(4), 255–262.
34.
WeissenbornR., RobbinsT. W., & EverittB. J.. (1997). Effects of medial prefrontal or anterior cingulate cortex lesions on responding for cocaine under fixed-ratio and second-order schedules of reinforcement in rats.Psychopharmacology, 134(3), 242–257.
35.
WilensT. E., BiedermanJ., MickE., FaraoneS. V., & SpencerT.. (1997). Attention Deficit Hyperactivity Disorder (ADHD) is associated with early onset substance use disorders.Journal of Nervous and Mental Disease, 185(8), 475–482.
